Cornelius Pauli

496 total citations
8 papers, 190 citations indexed

About

Cornelius Pauli is a scholar working on Molecular Biology, Cancer Research and Hematology. According to data from OpenAlex, Cornelius Pauli has authored 8 papers receiving a total of 190 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 3 papers in Cancer Research and 2 papers in Hematology. Recurrent topics in Cornelius Pauli's work include RNA modifications and cancer (5 papers), Cancer-related molecular mechanisms research (3 papers) and Acute Myeloid Leukemia Research (2 papers). Cornelius Pauli is often cited by papers focused on RNA modifications and cancer (5 papers), Cancer-related molecular mechanisms research (3 papers) and Acute Myeloid Leukemia Research (2 papers). Cornelius Pauli collaborates with scholars based in Germany, United States and Israel. Cornelius Pauli's co-authors include Carsten Müller‐Tidow, Christian Rohde, Yi Liu, Fengbiao Zhou, Lynne Staggs, Bayram Edemir, Patricia Schröder, Chunhong Cui, Jessica Kaufeld and Mario Schiffer and has published in prestigious journals such as Blood, Molecular Cell and Oncogene.

In The Last Decade

Cornelius Pauli

8 papers receiving 189 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Cornelius Pauli Germany 6 156 75 19 15 12 8 190
Pooja Shah United States 7 161 1.0× 58 0.8× 4 0.2× 3 0.2× 11 0.9× 17 227
Kimiyoshi Sakaguchi Japan 6 68 0.4× 26 0.3× 3 0.2× 17 1.1× 13 1.1× 16 141
Masaki Wake Japan 4 104 0.7× 39 0.5× 15 0.8× 3 0.2× 13 1.1× 7 171
Purba Nag Australia 7 95 0.6× 36 0.5× 20 1.1× 4 0.3× 25 2.1× 8 150
Paulynn Suyin Chin United Kingdom 9 154 1.0× 38 0.5× 2 0.1× 78 5.2× 14 1.2× 16 204
Shirley Nah United States 3 74 0.5× 8 0.1× 6 0.3× 24 1.6× 31 2.6× 6 138
Ana P. Kutschat United States 7 98 0.6× 17 0.2× 10 0.5× 8 0.5× 20 1.7× 9 134
Clarissa von Haefen Germany 4 109 0.7× 24 0.3× 2 0.1× 12 0.8× 10 0.8× 4 164
Yuzhang Jiang China 6 81 0.5× 43 0.6× 4 0.2× 2 0.1× 16 1.3× 23 147

Countries citing papers authored by Cornelius Pauli

Since Specialization
Citations

This map shows the geographic impact of Cornelius Pauli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cornelius Pauli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cornelius Pauli more than expected).

Fields of papers citing papers by Cornelius Pauli

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cornelius Pauli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cornelius Pauli. The network helps show where Cornelius Pauli may publish in the future.

Co-authorship network of co-authors of Cornelius Pauli

This figure shows the co-authorship network connecting the top 25 collaborators of Cornelius Pauli. A scholar is included among the top collaborators of Cornelius Pauli based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cornelius Pauli. Cornelius Pauli is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Milenkovic, Ivan, Sonia Cruciani, Laia Llovera, et al.. (2024). Epitranscriptomic rRNA fingerprinting reveals tissue-of-origin and tumor-specific signatures. Molecular Cell. 85(1). 177–190.e7. 8 indexed citations
2.
Schmidt, Christina, Christian Rohde, Cornelius Pauli, et al.. (2023). The ribosomal protein S6 kinase alpha-1 (RPS6KA1) induces resistance to venetoclax/azacitidine in acute myeloid leukemia. Leukemia. 37(8). 1611–1625. 14 indexed citations
3.
Waclawiczek, Alexander, Stefanie Göllner, Daniel Heid, et al.. (2022). Protein tyrosine kinase 2b inhibition reverts niche-associated resistance to tyrosine kinase inhibitors in AML. Leukemia. 36(10). 2418–2429. 12 indexed citations
4.
Pauli, Cornelius, Christian Rohde, Anna Luise Grab, et al.. (2022). PB1976: CRISPR-CAS9 KNOCKOUT SCREEN IDENTIFIES RNA MODIFICATION ENZYMES ESSENTIAL FOR CELL SURVIVAL IN MULTIPLE MYELOMA. HemaSphere. 6. 1849–1850. 1 indexed citations
5.
Pauli, Cornelius, et al.. (2021). Epitranscriptomic modifications in acute myeloid leukemia: m6A and 2′-O-methylation as targets for novel therapeutic strategies. Biological Chemistry. 402(12). 1531–1546. 3 indexed citations
6.
Pauli, Cornelius, Yi Liu, Christian Rohde, et al.. (2020). Site-specific methylation of 18S ribosomal RNA by SNORD42A is required for acute myeloid leukemia cell proliferation. Blood. 135(23). 2059–2070. 59 indexed citations
7.
Cui, Chunhong, Yi Liu, Dennis Gerloff, et al.. (2020). NOP10 predicts lung cancer prognosis and its associated small nucleolar RNAs drive proliferation and migration. Oncogene. 40(5). 909–921. 39 indexed citations
8.
Hanke, Nils, Lynne Staggs, Patricia Schröder, et al.. (2013). “Zebrafishing” for Novel Genes Relevant to the Glomerular Filtration Barrier. BioMed Research International. 2013. 1–12. 54 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026